199 related articles for article (PubMed ID: 11565511)
1. Summary: EU standards measurements and testing project PL95-3407. Development of a standardised in vitro methodology for hepatic and renal toxicity testing.
Hartung T
Altern Lab Anim; 2001; 29(4):493-5. PubMed ID: 11565511
[No Abstract] [Full Text] [Related]
2. Towards an integrated in vitro strategy for repeated dose toxicity testing.
Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
[No Abstract] [Full Text] [Related]
3. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
Rogiers V
Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
[No Abstract] [Full Text] [Related]
4. Validation is a key theme in this issue of ALTEX.
von Aulock S
ALTEX; 2011; 28(1):1. PubMed ID: 21404727
[No Abstract] [Full Text] [Related]
5. The patchwork of toxicological research for pharmaceutical testing.
von Aulock S
ALTEX; 2010; 27(1):1. PubMed ID: 20397314
[No Abstract] [Full Text] [Related]
6. Three Rs Approaches in Marine Biotoxin Testing. The Report and Recommendations of a joint ECVAM/DG SANCO Workshop (ECVAM Workshop 54).
Hess P; Grune B; Anderson DB; Aune T; Botana LM; Caricato P; van Egmond HP; Halder M; Hall S; Lawrence JF; Moffat C; Poletti R; Richmond J; Rossini GP; Seamer C; Vilageliu JS;
Altern Lab Anim; 2006 May; 34(2):193-224. PubMed ID: 16704292
[No Abstract] [Full Text] [Related]
7. Integrated testing strategy (ITS) for bioaccumulation assessment under REACH.
Lombardo A; Roncaglioni A; Benfentati E; Nendza M; Segner H; Fernández A; Kühne R; Franco A; Pauné E; Schüürmann G
Environ Int; 2014 Aug; 69():40-50. PubMed ID: 24806447
[TBL] [Abstract][Full Text] [Related]
8. Introduction to the EU REACH legislation.
Grindon C; Combes R
Altern Lab Anim; 2008 Oct; 36 Suppl 1():1-6. PubMed ID: 19025328
[TBL] [Abstract][Full Text] [Related]
9. Integrated decision-tree testing strategies for environmental toxicity with respect to the requirements of the EU REACH legislation.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2008 Oct; 36 Suppl 1():29-42. PubMed ID: 19025330
[TBL] [Abstract][Full Text] [Related]
10. Validation of alternative tests in the European Union.
Balls M
Curr Probl Dermatol; 1995; 23():265-74. PubMed ID: 9035921
[No Abstract] [Full Text] [Related]
11. Is there a need in regulatory toxicity testing for evaluating chemicals at doses eliciting general toxicity?
Chahoud I; Grote K
Toxicology; 2016 Jul; 363-364():46-7. PubMed ID: 27430607
[No Abstract] [Full Text] [Related]
12. Novel advanced in vitro methods for long-term toxicity testing: the report and recommendations of ECVAM workshop 45. European Centre for the Validation of Alternative Methods.
Pfaller W; Balls M; Clothier R; Coecke S; Dierickx P; Ekwall B; Hanley BA; Hartung T; Prieto P; Ryan MP; Schmuck G; Sladowski D; Vericat JA; Wendel A; Wolf A; Zimmer J
Altern Lab Anim; 2001; 29(4):393-426. PubMed ID: 11506637
[No Abstract] [Full Text] [Related]
13. An integrated decision-tree testing strategy for repeat dose toxicity with respect to the requirements of the EU REACH legislation.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2008 Feb; 36(1):93-101. PubMed ID: 18333717
[TBL] [Abstract][Full Text] [Related]
14. Integrated testing strategies for use with respect to the requirements of the EU REACH legislation.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2008 Oct; 36 Suppl 1():7-27. PubMed ID: 19025329
[TBL] [Abstract][Full Text] [Related]
15. OECD Test Guidelines are tools, not blueprints, for chemical safety assessment.
Phillips B
Altern Lab Anim; 2006 Feb; 34(1):115-7. PubMed ID: 16522155
[No Abstract] [Full Text] [Related]
16. Eye irritation.
Eskes C; Bessou S; Bruner L; Curren R; Harbell J; Jones P; Kreiling R; Liebsch M; McNamee P; Pape W; Prinsen MK; Seidle T; Vanparys P; Worth A; Zuang V
Altern Lab Anim; 2005 Jul; 33 Suppl 1():47-81. PubMed ID: 16194141
[No Abstract] [Full Text] [Related]
17. Status and prospects of in vitro tests in risk assessment.
Louekari K
Altern Lab Anim; 2004 Oct; 32(4):431-5. PubMed ID: 15651929
[TBL] [Abstract][Full Text] [Related]
18. Analysis and reflection on the role of the 90-day oral toxicity study in European chemical risk assessment.
Vrolijk M; Deluyker H; Bast A; de Boer A
Regul Toxicol Pharmacol; 2020 Nov; 117():104786. PubMed ID: 32976858
[TBL] [Abstract][Full Text] [Related]
19. An integrated decision-tree testing strategy for repeat dose toxicity with respect to the requirements of the EU REACH legislation.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2008 Oct; 36 Suppl 1():139-47. PubMed ID: 19025337
[TBL] [Abstract][Full Text] [Related]
20. Validation of alternative methods for toxicity testing.
Bruner LH; Carr GJ; Curren RD; Chamberlain M
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):477-84. PubMed ID: 9599695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
